|
1
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cormier JN and Pollock RE: Soft tissue
sarcomas. CA Cancer J Clin. 54:94–109. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Janeway KA and Grier HE: Sequelae of
osteosarcoma medical therapy: A review of rare acute toxicities and
late effects. Lancet Oncol. 11:670–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Picci P, Ferrari S, Bacci G and
Gherlinzoni F: Treatment recommendations for osteosarcoma and adult
soft tissue sarcomas. Drugs. 47:82–92. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meyers PA: Muramyl tripeptide
(mifamurtide) for the treatment of osteosarcoma. Expert Rev
Anticancer Ther. 9:1035–1049. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gorlick R, Anderson P, Andrulis I, Arndt
C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D,
et al: Biology of childhood osteogenic sarcoma and potential
targets for therapeutic development: Meeting summary. Clin Cancer
Res. 9:5442–5453. 2003.PubMed/NCBI
|
|
8
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park CY, Tseng D and Weissman IL: Cancer
stem cell-directed therapies: Recent data from the laboratory and
clinic. Mol Ther. 17:219–230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Korkaya H and Wicha MS: Selective
targeting of cancer stem cells: A new concept in cancer
therapeutics. BioDrugs. 21:299–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma S, Lee TK, Zheng BJ, Chan KW and Guan
XY: CD133+ HCC cancer stem cells confer chemoresistance
by preferential expression of the Akt/PKB survival pathway.
Oncogene. 27:1749–1758. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Adhikari AS, Agarwal N, Wood BM, Porretta
C, Ruiz B, Pochampally RR and Iwakuma T: CD117 and Stro-1 identify
osteosarcoma tumor-initiating cells associated with metastasis and
drug resistance. Cancer Res. 70:4602–4612. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luu HH, Kang Q, Park JK, Si W, Luo Q,
Jiang W, Yin H, Montag AG, Simon MA, Peabody TD, et al: An
orthotopic model of human osteosarcoma growth and spontaneous
pulmonary metastasis. Clin Exp Metastasis. 22:319–329. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Savage S.A..Mirabello L: Using
epidemiology and genomics to understand osteosarcoma etiology.
Sarcoma, 2011. 2011.548151
|
|
17
|
Ek ET, Dass CR and Choong PF: Commonly
used mouse models of osteosarcoma. Crit Rev Oncol Hematol. 60:1–8.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen X, Li Y, Xiong K, Aizicovici S, Xie
Y, Zhu Q, et al: Cancer gene therapy by direct tumor injections of
a nonviral T7 vector encoding a thymidine kinase gene. Human Gene
Ther. 1998.9(5): 729–36. View Article : Google Scholar
|
|
19
|
Crnalic S, Hakansson I, Boquist L,
Lofvenberg R and Brostrom LA: A novel spontaneous metastasis model
of human osteosarcoma developed using orthotopic transplantation of
intact tumor tissue into tibia of nude mice. Clin Exp Metastasis.
1997.15(2): 164–72. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vergote J, Moretti JL, de Vries EG and
Garnier-Suillerot A: Comparison of the kinetics of active efflux of
99mTc-MIBI in cells with P-glycoprotein-mediated and
multidrug-resistance protein-associated multidrug-resistance
phenotypes. Eur J Biochem. 252:140–146. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suto R, Abe Y, Nakamura M, Ohnishi Y,
Yoshimura M, Lee YH, Imanishi T, Yamazaki H, Kijima H, Tokunaga T,
et al: Multidrug resistance mediated by overexpression of
P-glycoprotein in human osteosarcoma in vivo. Int J Oncol.
12:287–291. 1998.PubMed/NCBI
|
|
22
|
Chan HS, Grogan TM, Haddad G, DeBoer G and
Ling V: P-glycoprotein expression: Critical determinant in the
response to osteosarcoma chemotherapy. J Natl Cancer Inst.
89:1706–1715. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Burak Z, Moretti JL, Ersoy O, Sanli U,
Kantar M, Tamgac F and Basdemir G: 99mTc-MIBI imaging as a
predictor of therapy response in osteosarcoma compared with
multidrug resistance-associated protein and P-glycoprotein
expression. J Nucl Med. 44:1394–1401. 2003.PubMed/NCBI
|
|
24
|
Dutour A, Leclers D, Monteil J, Paraf F,
Charissoux JL, Rousseau R and Rigaud M: Non-invasive imaging
correlates with histological and molecular characteristics of an
osteosarcoma model: Application for early detection and follow-up
of MDR phenotype. Anticancer Res. 27:4171–4178. 2007.PubMed/NCBI
|
|
25
|
Beachy PA, Karhadkar SS and Berman DM:
Tissue repair and stem cell renewal in carcinogenesis. Nature.
432:324–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ravandi F, Burnett AK, Agura ED and
Kantarjian HM: Progress in the treatment of acute myeloid leukemia.
Cancer. 110:1900–1910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Woodward WA and Sulman EP: Cancer stem
cells: Markers or biomarkers? Cancer Metastasis Rev. 27:459–470.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hay DC, Sutherland L, Clark J and Burdon
T: Oct-4 knockdown induces similar patterns of endoderm and
trophoblast differentiation markers in human and mouse embryonic
stem cells. Stem Cells. 22:225–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boyer LA, Lee TI, Cole MF, Johnstone SE,
Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG,
et al: Core transcriptional regulatory circuitry in human embryonic
stem cells. Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei H, Zhao MQ, Dong W, Yang Y and Li JS:
Expression of c-kit protein and mutational status of the c-kit gene
in osteosarcoma and their clinicopathological significance. J Int
Med Res. 36:1008–1014. 2008. View Article : Google Scholar : PubMed/NCBI
|
